morning schedule


DOSED: The Trip of a Lifetime

PSBE is proud to welcome you to the screening of the award-winning documentary “DOSED: The Trip of a Lifetime”.

Laurie,a loving mother of four is granted the right to legally use magic mushrooms to treat her end of life anxiety.

She then embarks on a remarkable journey of personal transformation and healing while exploring lesser known possible cures for cancer, like cannabis oil.
The screening will be introduced by Spencer Hawkswell, founder and CEO of TheraPsil, the Canadian non-profit that helped Laurie and many other Canadians get a legal exemption to obtain compassionate use of psilocybin. He will also answer questions after the screening.
  • Cinéma Palace Brussels
  • Anspachlaan 85, 1000 Brussels
  • Saturday, October 7 – start: 11h

AFTERNOON schedule

PSBE welcomes you to our Symposium on Psychedelics & Palliative care.
We are honored to provide the stage for some brilliant researchers and host the event for all interested parties.


EASING THE Ultimate Journey


  • MAI, Maison des Associations internationales
  • Rue Washington 40, Brussels
  • Saturday, October 7 – start: 14h



PSBE members have a discount. You can find the discount code on our Slack Platform.


Dr. Bill Richards

Research psychologist at the Center for Psychedelic & Consciousness Research (Johns Hopkins)

Dr Bill Richards has been a psychologist in the Psychiatry Department of the Johns Hopkins University School of Medicine since 1999, when he and Roland Griffiths launched the rebirth of psilocybin research after a 22-year period of dormancy.
His involvement with psilocybin research originated in 1963 and between 1967-1977, he implemented projects of psychotherapy research with LSD, DPT, MDA and psilocybin at the Maryland Psychiatric Research Center, including protocols designed to investigate the promise of psychedelics in the treatment of alcoholism, depression, narcotic addiction and the psychological distress associated with terminal cancer, and also their use in the training of religious and mental-health professionals.
His recent research at Johns Hopkins has focused on the potential value of psilocybin in the continuing education of professional religious leaders from different world religions. His book, “Sacred Knowledge: Psychedelics and Religious Experiences” has been translated into multiple additional languages.

Stéphanie Chayet

Freelance journalist

Stéphanie Chayet is a freelance journalist formerly based in New York, correspondant for Le Monde magazine. Following an investigation for this publication, she took a more personal interest in the medical use of psychedelic substances. She published the book “Phantastica: ces substances interdites qui guérissent” in 2020, where she recounts her own personal journey dealing with cancer and its associated existential distress.

Stéphanie will recount her transformative experience as well as her interviews with the American pioneers who are working tirelessly to bring this therapeutic resource to the field of palliative care.

Spencer Hawkswell

CEO TheraPsil

Spencer Hawkswell is the president & CEO of TheraPsil (Canada), a small non-profit coalition dedicated to helping Canadians in medical need access legal psilocybin-assisted psychotherapy and medical psilocybin. In August 2020, after over 100 days of advocating, TheraPsil facilitated precedent-setting and tangible progress in the fight for compassionate access to psilocybin therapy when they helped 4 Canadians suffering from end-of-life distress, due to a terminal illness, access approved exemptions from the Minister of Health. Since this landmark moment, TheraPsil facilitated several dozens more similar exemptions.

Spencer’s presentation will review how advocacy has helped expand access to psilocybin and MDMA in Canada. The role of advocacy in political decision-making and the need for framing access as compassionate for those who have no other options.

Dr. Sivan Schipper

Medical doctor

Dr. Sivan Schipper is the Head of Palliative Medicine at the Uster hospital in Zurich, and is the driving force behind an upcoming study on psychedelics and end-of-life care that is planned to begin at the hospital at the end of this year. He has personally benefited from compassionate use of psychedelics for his cluster headaches.

Spiritual or Total Pain is a common problem at end of life. Psychedelic-assisted therapy at end of life is a medical intervention that can possibly catalyze patients’ psychospiritual processes, help them transcend their fear of death and overcome spiritual pain. In this talk, Swiss pioneering clinical studies will be highlighted and future perspectives of end-of-life care, including psychedelic-assisted therapy, will be presented.